2021
DOI: 10.1016/j.jiac.2021.07.017
|View full text |Cite
|
Sign up to set email alerts
|

Risk factors for acute kidney injury in vancomycin and piperacillin/tazobactam combination therapy: A retrospective study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…It is well established that AKI usually occurs in susceptible populations with high-risk factors or following certain specific medical procedures, and several previous studies have obtained more consistent conclusions on the evaluation of risk factors by analyzing the static and dynamic characteristics of a large number of AKI patients (3)(4)(5)(6)(7)(8). Based on the preventability of AKI and the ease of diagnosis, increasing research is focused on the early diagnosis of AKI, with the aim of early assessment of inpatients to determine their risk stratification, dynamic adjustment of treatment protocols, replacement of potentially dangerous medical orders, and interventions to avoid or reduce potential kidney injury and ultimately to achieve inpatient renal protection by reducing the incidence of AKI, avoiding a series of subsequent adverse events.…”
Section: Introductionmentioning
confidence: 99%
“…It is well established that AKI usually occurs in susceptible populations with high-risk factors or following certain specific medical procedures, and several previous studies have obtained more consistent conclusions on the evaluation of risk factors by analyzing the static and dynamic characteristics of a large number of AKI patients (3)(4)(5)(6)(7)(8). Based on the preventability of AKI and the ease of diagnosis, increasing research is focused on the early diagnosis of AKI, with the aim of early assessment of inpatients to determine their risk stratification, dynamic adjustment of treatment protocols, replacement of potentially dangerous medical orders, and interventions to avoid or reduce potential kidney injury and ultimately to achieve inpatient renal protection by reducing the incidence of AKI, avoiding a series of subsequent adverse events.…”
Section: Introductionmentioning
confidence: 99%